The American retail and pharmacy corporation CVS is looking to enter the metaverse according to trademark filings registered with the United States Patent and Trademark Office (USPTO). The filings mention things like CVS Health-brand “downloadable virtual goods” and “crypto-collectibles.”

CVS Trademark Filings Discuss Virtual Worlds and NFTs

The drugstore giant CVS has filed a series of trademark filings with the USPTO on February 28, 2022, and the registrations were published on March 4. The CVS-Health trademark filing #97287237 discusses a number of virtual items and non-fungible token (NFT) concepts. Section 1(a) in the filing states:

Downloadable virtual goods, namely, a variety of consumer goods, prescription drugs, health, wellness, beauty, personal care products, and general merchandise for use online and in online virtual worlds.

Similarly, section 1(b) is described in the same fashion but also with “digital assets and digital collectibles sold as non-fungible tokens (NFTs).” The CVS Health virtual goods and digital collectibles trademarks follow a slew of well known brands that have also filed similar metaverse-related trademarks with the USPTO.

The fast-food giant McDonald’s filed metaverse-related trademarks with the USPTO in mid-February, and Walmart filed metaverse and NFT-related trademarks in mid-January. New Balance, Puma, and Crocs have filed metaverse trademarks as well in recent times. The CVS trademark filings indicate that the concepts are meant to bolster “entertainment and amusement” and for “use in virtual environments.”

CVS’s NFT idea aims to provide “online digital artwork and images; crypto-collectibles and application tokens used and transferred on software as a service; crypto-collectibles and application tokens accessed on platform as a service; providing temporary use of non-downloadable digital media, namely, digital assets, digital collectibles, digital tokens and non-fungible tokens.”

What do you think about CVS filing for NFT and metaverse related trademarks with the USPTO? Let us know what you think about this subject in the comments section below.